A comparison of lisinopril and atenolol in black and Indian patients with mild-to-moderate essential hypertension. 1987

Y K Seedat, and K B Parag

The effects of lisinopril (MK-521; MSD) and atenolol in the treatment of mild-to-moderate essential hypertension were compared in a double-blind, parallel, controlled study, with 24 patients randomly assigned to lisinopril and 12 to atenolol. Patients in both groups whose blood pressure did not respond satisfactorily were given hydrochlorothiazide (HCTZ). The groups were matched for age, race and pretreatment blood pressure. Response to therapy was similar in the atenolol and lisinopril groups, but the combination of lisinopril and HCTZ produced a better response than atenolol plus HCTZ. Indian patients appeared to respond better to lisinopril than black patients, but the hypotensive response to lisinopril plus HCTZ was similar. Plasma renin activity rose and the plasma aldosterone level fell after taking lisinopril. Adverse effects did not occur and only 1 patient on lisinopril 20 mg/d was withdrawn from the study because of postural hypotension. Lisinopril alone and combined with HCTZ in Indian patients and lisinopril combined with HCTZ in black patients produced a satisfactory fall in blood pressure.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D005260 Female Females

Related Publications

Y K Seedat, and K B Parag
January 1991, The American journal of cardiology,
Y K Seedat, and K B Parag
January 1987, Journal of cardiovascular pharmacology,
Y K Seedat, and K B Parag
May 1999, American journal of therapeutics,
Y K Seedat, and K B Parag
January 1986, British journal of clinical pharmacology,
Y K Seedat, and K B Parag
April 1989, The American journal of medicine,
Y K Seedat, and K B Parag
January 1990, Clinical therapeutics,
Y K Seedat, and K B Parag
April 1990, British journal of clinical pharmacology,
Copied contents to your clipboard!